@Jonathan Edwards Do you recall saying on PR that Jo Cambridge's team had identified an abnormality in B cells that looked like the opposite of autoimmunity?
You weren't able to tell us more at the time but did anything ever come of that?
Whoop whoop! If true - great news. I always thought there would be a third who might respond.
Do please Jorgen Jelsted's Blog post about it. He talks about low response rates in Lupus studies, a disease known to involve B cells. It didnt turn out to be the hoped for treatment in Lupus at all. So, it doesnt mean something serious isnt going on, or that we dont have autoimmune issues. It will be interesting to see what they did learn from the study...
These are, are they not Dr Edwards, areas of research? Are any meds/ treatments being looked at?
RTX disappointment is huge, as you know, because folks and younger people thought, I'll scrimp my pennies together and get the RTX and get my life back.
Thanks.But I do not think there is any reason to do further rituximab trials in ME. We need to follow other leads.
Thanks.
General query, do you think the very original responders ( cancer patients) may actually have responded, but to something different in their chemotherapy ? Or any thoughts on this ?
It's unlikely placebo played a part in those patients I would say.
@Jonathan Edwards yet, there seems to be reasonable response to cyclophosphamide if they have moved onto stage B of the CycloME trial, giving it to the more severe patients. Would that not indicate autoimmunity for a subset?
This sort of situation has been playing on my mind.A true placebo response is only one of several reasons why people get better following treatments. I think it most likely that the original responses do not tell us anything useful about ME. They may have had immune dysfunction associated with lymphoma. The time course of immune dysfunction does not alaways follow the lymphoma in an obvious way so may appear to be a separate illness.
Without getting into a prolonged discussion about various criteria, yes and no. ME/CFS (CCC) does, CFS/ME (NICE) does, ME (ICC) does, SEID (IOM - clinical only) does, CFS (Fukuda/CDC1994) doesn't, [CFS (Oxford) doesn't but who cares, it's nonsense and for research only].Isn't PEM exclusive to ME. If you don't get pem, you don't have ME.
Well if they don't have PEM....they don't have ME. PEM is the crucifying part of ME that restricts our lives so much. I know any researcher with any knowledge of ME would not be using Oxford Criteria, that should be binned long ago.Without getting into a prolonged discussion about various criteria, yes and no. ME/CFS (CCC) does, CFS/ME (NICE) does, ME (ICC) does, SEID (IOM - clinical only) does, CFS (Fukuda/CDC1994) doesn't, [CFS (Oxford) doesn't but who cares, it's nonsense and for research only].
There must be a lot of people out there diagnosed under Fukuda who don't have PEM.
Post Exertional Malaise and/or Fatigue is also something of a grey area (CCC and NICE).
Yes but the crucial thing is that even though I was careful to use ME, CFS, ME/CFS and CFS/ME appropriately in this instance, terms are commonly used interchangeably.Well if they don't have PEM....they don't have ME. PEM is the crucifying part of ME that restricts our lives so much. I know any researcher with any knowledge of ME would not be using Oxford Criteria, that should be binned long ago.
Well if they don't have PEM....they don't have ME
But could effectiveness be measured pre- and post-treatment using a CPET?The problem with cyclophosphamide is that you cannot blind it because of the side effects. So the cyclo studies alone are not solid evidence.
Ive spent time on Lupus, MS, thyroid and Lyme boards in an attempt to get to the bottom of my ilness and a lot of people with htose illnesses report something similar to PEM.Watching a family member very closely, I see PEM with any exertion: mental, physical, emotion,cognitive. Depending on the intensity of the exertion, the PEM comes immediately, or a day after. It lasts very long, from a day or two until two weeks or more. PEM is also often present non stop, if our beloved tries to do minimal activities not to go insane: buy some thing on line, read, etc.
She has PEM, OI, flu feeling almost non stop, sick feeling, toxic feeling, weakness.
However, I spoke with a CFS/ Lyme doctor with decades of experience whom I'll leave unnamed who told me he doesn't think PEM is specific to this illness. I was not in a position to question further. But he went on to say other illnesses also have this. Is this true?
The obvious question: do cardiac patients get it?
I'm so heartbroken by the lack of diagnostics, lack of help, lack of treatments. It's like living in a time of TB consumption, before antibiotics.
I think of young John Keats often and his dying in Italy, and his unrealized personal life with Fanny Brawne. Now my daughter is in the identical agony, so is Whitney, so is Tom C., and thousands of other young people.
When will there be some help? Time is not on our side...
Only recently Ian Lipkin made the point that he thinks it's either several diseases or one disease with multiple sub-groups, I can't recall exactly which but it's in the recent Solve video interview.
I think we need to allow ourselves to feel the disappointment but this quote in the Invest in ME response is one to remember
![]()
One day the research will get there but ok totoday because it isn’t imminent
Re different phases:
Do we think there’s a placebo/demand characteristic type thing going on? If they were expecting positive results up until the unblinding it perhaps points to that? Did people in the placebo arm also respond?
But I always thought placebo was unlikely in the first two phases because of the weird delayed response, which I don’t think participants would know to expect. Need to wait for more info.
I guess my question is: does this work at a biological level for fewer pwme than we hoped OR was it a false positive that it worked in the previous studies?
Will other studies now not go ahead? @Jonathan Edwards @Jo Best
We would caution that nothing is certain yet. We hope to meet with the researchers and there are still grounds for optimism. One of the reasons that an early statement was made by the Haukeland team was to avoid patients going for treatment outside of clinical trials and with unselected patients . One of the reasons for the delay in the UK trial of this drug has been due to the desire to find likely responders and it is this caution that the Norwegian researchers have brought out in their results. So we await more news. Stay hopeful until we hear more.
We have an excellent research team in Norway which has served the ME patient community and their families with honesty, integrity, professionalism, determination and an empathy which had never been seen before in this field.
We have established good working relationships between the Norwegian researchers and the UK Centre with input from UCL and UEA/Quadram Institute.
We have data now – more than before.
We have research which IiMER has established and a foundation for the Centre of Excellence for ME.
We have international collaboration in research into ME that will continue.
And we have new plans – already in the making.
The researchers from Haukeland will give more detail on their results and publish a paper or two which will benefit all studying ME.
For us, we have invited the Haukeland team to Norwich to discuss the way forward.
We remain positive. Another setback, another day.
We have already been in discussion with our advisors and with the Norwegian team and we will meet to clarify the best way forward in the near future with our major funder and researchers.
We still have much good research being funded and being planned and feel our stategy is, and will pay off and lead to the most rapid route to finding cause(s) of ME and effective treatments.
http://www.investinme.org/IIMER-Newslet-1711-03.shtml